Imfinzi (durvalumab) - AstraZeneca
PVX-410 - OncoPep
Hiltonol (poly-ICLC) - Oncovir
http://clinicaltrials.gov/ct2/show/NCT02826434
 
Oct 2, 2025
 
Next